Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis

Improving understanding of the underlying pathophysiology of giant cell arteritis (GCA) is transforming clinical management by identifying novel avenues for targeted therapies. One key area of concern for both clinicians and patients with GCA is glucocorticoid (GC) morbidity. The first randomised co...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mousawi, Alia Z., Gurney, Sam P., Lorenzi, Alice R., Pohl, Ute, Dayan, Margaret, Mollan, Susan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513947/
https://www.ncbi.nlm.nih.gov/pubmed/30820767
http://dx.doi.org/10.1007/s40123-019-0171-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513947/
https://www.ncbi.nlm.nih.gov/pubmed/30820767
http://dx.doi.org/10.1007/s40123-019-0171-0

Ejemplares similares